JPRN-UMIN000009761已完成未知
Oral L-Carnitine Treatment in Hepatic Encephalopathy - Oral L-Carnitine Stydy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient's prognosis is shorter than 6 months. 2. Child Pugh grade C 3. Spontaneous bacterial peritonitis 4. Alcoholism or antipsychotic drug user 5. Gastrointestinal hemorrhage 6. The placement of TIPS, B-RTO, or PSE. 7. Patients who judged inappropriate by researcher.
研究者
相似试验
已完成
不适用
Acetyl-L-Carnitine In Severe Hepatic EncephalopathyHepatic Encephalopathy (Grade 3 of the West Haven Grading Scale)NCT01223768University of Catania
已完成
4 期
L-ornithine L-aspartate in Overt Hepatic EncephalopathyCirrhosis of LiverHepatic EncephalopathyNCT01722578Dayanand Medical College and Hospital200
已完成
不适用
A pilot study of L-carnitine supplement for liver cirrhosisiver cirrhosisJPRN-UMIN000009188Kyoto Prefectural University of Medicine20
招募中
3 期
Effect of oral L-carnitine on echocardiography of dialysis patientspulmonary hypertension.Other secondary pulmonary hypertensionI27.2IRCT20230425057989N1Shahre-kord University of Medical Sciences40
尚未招募
不适用
The significance of oral L-carnitine administration in liver cirrhotic patients -a comparative study of treatment efficacy and safety between L-carnitine and lactulose in patients with minimal hepatic encephalopathyliver cirrhosisJPRN-UMIN000021808Kobe University Hospital Division of Gastroenterology60